{"ticker": {"uuid": "f6173bbe-95b7-4b6d-a943-9a5f9b3dfe02", "symbol": "BMYS", "name": "Bristol-Myers Squibb Company", "exchange": "VIE", "country": "AT", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Bristol Myers Squibb vs Pfizer Dividend Stock Comparison 2026 - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPbnpqeEtSMm5FMU05YXdUcktib3AzTUJONG1nVEVqV0FDeTNORnFyYVRFempkYXFSU2lhSGJldFVKXzZWM2hubkJlSWR4WU4zQkRUT2lkWmlhRi1LT3JUYkhDR01kYUFVMjE4Tm0zZlYtRGRDVlRIWF9XUk1sSFFBNkFfSzZzMlpjSGE2Yk5jSXBLWDlXVy1ac2t6WmlIT0VmYUdKMw?oc=5", "source_name": "IndexBox", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 questions to our new board member: J\u00e9rome Garcin, General Manager for Switzerland and Austria bei Bristol Myers Squibb", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxQbG1aTmx2VTBaQjlLYTBLWFVRZFRKVzhQZ2Q0U3hnWnEyaWJzN0VhbU4yMm9NN3pvZVRDWl81Tnd0cHNZX18xaFN4M1djX2NCQ2hlOHhoOVdUVjZYSmU5YkV6NDZYUXp2WV8wbWxOYVktd0RDWUZ3ZUtDOWo0QXJVV3Y1SGNsdFhGTTM5bmwwLWNjalltTEJiZTVyeTIzMFhJcWlUSmpxU3VxZDk2bC1vY1R6SlNaX2IwbEd1UW9veHNXX01VdG42ODc4clNWUHJlM1MxSU5ERWZHdHBPbDJ3ckhUMFV2RXRJZmc?oc=5", "source_name": "interpharma.ch", "published_at": "2026-05-26T15:42:56+00:00", "published_display": "26 May 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMY - Bristol-Myers Squibb Co Stock Price and Quote", "summary": "", "url": "https://news.google.com/rss/articles/CBMiREFVX3lxTFBFU1ljSEdnUXV1ZUw4NlQxbnpsWnlrUFE3RDU5Y2xBZ1dLX2RSamlSRV9aNXFtLWNXN05fRnNNcW1qQWZ0?oc=5", "source_name": "Finviz", "published_at": "2026-05-26T14:42:59+00:00", "published_display": "26 May 2026 14:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb stock price forecast: consolidation likely as BMY eyes upper range resistance", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNYTJpcWl3RUdxeWFySFNHd09nX3VPV0ZrcFdWanJ4bV9xVXB1UkRsYU1pWHlGOHRhaWVyTGxGNjhYZUNRd2lIbkxBdWlnWVdkMkRVOVV3Z252N2ZIQnhiYzdVMGZ2dW9EOThkUjQya05sZ3h5ZHhmY3Z1V3p1aEstZkN4QnBlNmYtVVdWNXktWWNmODd1YVBWZ3EyYw?oc=5", "source_name": "Traders Union", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb\u2019s Reblozyl reinforces market share in first-line MDS Space", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQOEQzZUUyRHFJWHhfWU5hYXUxNGNLUkNkUnRFbUxrdWV5Y2NVWnJ2ems1Y0dILV9ZMFpUYjlOaWRhekZyc1k0UHZvM0ZrUDYwRVV6d2lFQU9IZkhYMjh6dFROZUI5SXRaeVhwQ0Q0Sm1SS1JvYTFOTmlzUDNpVW94QnBPczdFMnJwT05vejVjd0JlWEJBb1FFY2xsOWV1TGViSk1SWXRNZlJlX19HWUxhbWlKUVEzOHI3OW9qQlIzUmllZzJITmUwMTloeGZGeTNBc0E?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2023-09-13T07:00:00+00:00", "published_display": "13 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Bristol Myers Squibb vs Pfizer Dividend Stock Comparison 2026 - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPbnpqeEtSMm5FMU05YXdUcktib3AzTUJONG1nVEVqV0FDeTNORnFyYVRFempkYXFSU2lhSGJldFVKXzZWM2hubkJlSWR4WU4zQkRUT2lkWmlhRi1LT3JUYkhDR01kYUFVMjE4Tm0zZlYtRGRDVlRIWF9XUk1sSFFBNkFfSzZzMlpjSGE2Yk5jSXBLWDlXVy1ac2t6WmlIT0VmYUdKMw?oc=5", "source_name": "IndexBox", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 questions to our new board member: J\u00e9rome Garcin, General Manager for Switzerland and Austria bei Bristol Myers Squibb", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxQbG1aTmx2VTBaQjlLYTBLWFVRZFRKVzhQZ2Q0U3hnWnEyaWJzN0VhbU4yMm9NN3pvZVRDWl81Tnd0cHNZX18xaFN4M1djX2NCQ2hlOHhoOVdUVjZYSmU5YkV6NDZYUXp2WV8wbWxOYVktd0RDWUZ3ZUtDOWo0QXJVV3Y1SGNsdFhGTTM5bmwwLWNjalltTEJiZTVyeTIzMFhJcWlUSmpxU3VxZDk2bC1vY1R6SlNaX2IwbEd1UW9veHNXX01VdG42ODc4clNWUHJlM1MxSU5ERWZHdHBPbDJ3ckhUMFV2RXRJZmc?oc=5", "source_name": "interpharma.ch", "published_at": "2026-05-26T15:42:56+00:00", "published_display": "26 May 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMY - Bristol-Myers Squibb Co Stock Price and Quote", "summary": "", "url": "https://news.google.com/rss/articles/CBMiREFVX3lxTFBFU1ljSEdnUXV1ZUw4NlQxbnpsWnlrUFE3RDU5Y2xBZ1dLX2RSamlSRV9aNXFtLWNXN05fRnNNcW1qQWZ0?oc=5", "source_name": "Finviz", "published_at": "2026-05-26T14:42:59+00:00", "published_display": "26 May 2026 14:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol-Myers Squibb stock price forecast: consolidation likely as BMY eyes upper range resistance", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNYTJpcWl3RUdxeWFySFNHd09nX3VPV0ZrcFdWanJ4bV9xVXB1UkRsYU1pWHlGOHRhaWVyTGxGNjhYZUNRd2lIbkxBdWlnWVdkMkRVOVV3Z252N2ZIQnhiYzdVMGZ2dW9EOThkUjQya05sZ3h5ZHhmY3Z1V3p1aEstZkN4QnBlNmYtVVdWNXktWWNmODd1YVBWZ3EyYw?oc=5", "source_name": "Traders Union", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bristol Myers Squibb\u2019s Reblozyl reinforces market share in first-line MDS Space", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxQOEQzZUUyRHFJWHhfWU5hYXUxNGNLUkNkUnRFbUxrdWV5Y2NVWnJ2ems1Y0dILV9ZMFpUYjlOaWRhekZyc1k0UHZvM0ZrUDYwRVV6d2lFQU9IZkhYMjh6dFROZUI5SXRaeVhwQ0Q0Sm1SS1JvYTFOTmlzUDNpVW94QnBPczdFMnJwT05vejVjd0JlWEJBb1FFY2xsOWV1TGViSk1SWXRNZlJlX19HWUxhbWlKUVEzOHI3OW9qQlIzUmllZzJITmUwMTloeGZGeTNBc0E?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2023-09-13T07:00:00+00:00", "published_display": "13 Sep 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 74, "total_relevant": 5, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 5, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 68, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 50.17, "latest_week": "2026-07-10", "one_week_move": -0.3, "four_week_move": 3.1, "twelve_week_move": -1.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.618692, "market_dynamics_buy_signal": false, "relative_strength": -7.79024, "fair_value_gap": 14.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 53.9692, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.3% over one week, +3.1% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 44, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "IndexBox", "count": 1}, {"label": "interpharma.ch", "count": 1}, {"label": "Finviz", "count": 1}, {"label": "Traders Union", "count": 1}, {"label": "Pharmaceutical Technology", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Capital return", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "68/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-0.3% over one week, +3.1% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Bristol Myers Squibb vs Pfizer Dividend Stock Comparison 2026 - News and Statistics"}], "updated_at": "2026-07-17T23:11:22.573062+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}